Found: 15
Select item for more details and to access through your institution.
Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatment.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Bortezomib interactions with chemotherapy agents in acute leukemia in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 13, doi. 10.1007/s00280-005-0135-z
- By:
- Publication type:
- Article
Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 24, doi. 10.1007/s00280-005-0137-x
- By:
- Publication type:
- Article
CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 35, doi. 10.1007/s00280-005-0136-y
- By:
- Publication type:
- Article
Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 40, doi. 10.1007/s00280-005-0144-y
- By:
- Publication type:
- Article
Human breast cell lines exhibit functional α<sub>2</sub>-adrenoceptors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 50, doi. 10.1007/s00280-005-0130-4
- By:
- Publication type:
- Article
Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 62, doi. 10.1007/s00280-005-0127-z
- By:
- Publication type:
- Article
Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 86, doi. 10.1007/s00280-005-0114-4
- By:
- Publication type:
- Article
p53 Status does not affect photodynamic cell killing induced by hypericin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 91, doi. 10.1007/s00280-005-0131-3
- By:
- Publication type:
- Article
Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 99, doi. 10.1007/s00280-005-0133-1
- By:
- Publication type:
- Article
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Enforced expression of cytosolic 5′-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 117, doi. 10.1007/s00280-005-0156-7
- By:
- Publication type:
- Article
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 129, doi. 10.1007/s00280-005-0132-2
- By:
- Publication type:
- Article
5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 136, doi. 10.1007/s00280-005-0129-x
- By:
- Publication type:
- Article